{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:38:48Z","timestamp":1792975128845,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1053\/j.ajkd.2003.08.011","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T13:07:31Z","timestamp":1070370451000},"page":"1114-1120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome"],"prefix":"10.1053","volume":"42","author":[{"given":"Arvind","family":"Bagga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Moudgil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley C","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2003.08.011_BIB1","series-title":"Pediatric Nephrology","first-page":"128","article-title":"Nephrotic syndrome","author":"Srivastava","year":"2001"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004670000523","article-title":"A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children","volume":"16","author":"Latta","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s004670050307","article-title":"Levamisole therapy in corticosteroid-dependent nephrotic syndrome","volume":"11","author":"Bagga","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB4","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1046\/j.1523-1755.2001.0590051919.x","article-title":"Immunosuppressive agents in childhood nephrotic syndrome","volume":"59","author":"Durkan","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB5","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2002.00303.x","article-title":"Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome","volume":"61","author":"Iijima","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/ajkd.1998.v31.pm9469489","article-title":"Successful mycophenolate mofetil treatment of glomerular disease","volume":"31","author":"Briggs","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB7","series-title":"Comprehensive Clinical Nephrology","first-page":"22.1","article-title":"Minimal change disease and primary focal segmental glomerulosclerosis","author":"Mason","year":"2000"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB8","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1523-1755.2002.00214.x","article-title":"Mycophenolate mofetil treatment for primary glomerular diseases","volume":"61","author":"Choi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s004670050047","article-title":"Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil","volume":"14","author":"Chandra","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB10","first-page":"975","article-title":"Indian Academy of Pediatrics","volume":"38","year":"2001","journal-title":"Indian Pediatr"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004670050708","article-title":"Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome","volume":"13","author":"Bagga","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB12","series-title":"NCHS Growth Curves for Children","year":"1978"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB13","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/ndt\/17.11.2011","article-title":"Mycophenolate mofetil in the treatment of resistant nephrotic syndrome","volume":"17","author":"Day","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB14","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group","volume":"343","author":"Chan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB15","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/ajkd.2000.8968","article-title":"Use of mycophenolate mofetil in resistant membranous nephropathy","volume":"36","author":"Miller","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0272-6386(99)70358-6","article-title":"Mycophenolate mofetil in cadaveric renal transplantation","volume":"34","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1681\/ASN.V981511","article-title":"Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients","volume":"9","author":"Weber","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2003.08.011_BIB19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.V133759","article-title":"The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients","volume":"13","author":"Weber","year":"2002","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603010989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603010989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:22:19Z","timestamp":1759454539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638603010989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0272638603010989"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2003.08.011","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2003.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}